These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3742982)

  • 1. [Muzolimine in liver cirrhosis and essential arterial hypertension].
    Salerno L; Pepe S; Sallì L; Scalici G; Curiale B; Salvato F
    Clin Ter; 1986 Jul; 118(2):99-107. PubMed ID: 3742982
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative study of muzolimine and acebutolol in the treatment of moderate hypertension.
    Lucsko M; Kerihuel JC; Chaignon M; Aubert PH; Guedon J
    Z Kardiol; 1985; 74 Suppl 2():73-6. PubMed ID: 3890394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and hemodynamic effects of medium-term treatment with muzolimine in subjects with essential arterial hypertension].
    Licata G; Scaglione R; Parrinello G; Rini GB; Asta N
    G Ital Cardiol; 1986 Jul; 16(7):583-5. PubMed ID: 3781147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of muzolimine and indapamide during treatment for essential hypertension.
    Kirsten R; Molz KH; Tzonev I; Nelson K
    Z Kardiol; 1985; 74 Suppl 2():66-72. PubMed ID: 4002807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term, high-dose muzolimine treatment in patients with chronic renal failure and acute fluid retention.
    Orsoni G; Di Felice A; Hadjigavriel M; Biavati M; Bonomini V
    Z Kardiol; 1985; 74 Suppl 2():121-4. PubMed ID: 4002785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muzolimine in chronic renal failure: a study in 16 patients.
    Stratta P; Dogliani M; Squiccimarro G; Colla L; Vercellone A
    Z Kardiol; 1985; 74 Suppl 2():125-8. PubMed ID: 4002786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muzolimine in advanced chronic renal failure.
    Mastrangelo F; Rizzelli S; Corlianò C; Alfonso L; De Blasi V; Aprile M; Montinaro AM; Napoli M
    Z Kardiol; 1985; 74 Suppl 2():109-14. PubMed ID: 4002783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of mild to moderate essential hypertension with muzolimine. Two years of follow-up.
    Amabile G; Serradimigni A
    Z Kardiol; 1985; 74 Suppl 2():48-51. PubMed ID: 4002804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative pharmacodynamics of furosemide and muzolimine in cirrhosis. Study on renal sodium and potassium handling and renin-aldosterone axis.
    Bernardi M; De Palma R; Trevisani F; Santini C; Servadei D; Gasbarrini G
    Z Kardiol; 1985; 74 Suppl 2():129-34. PubMed ID: 3890391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of muzolimine and a fixed combination of diuretics in essential hypertension.
    Wicker P; Clementy J
    Clin Pharmacol Ther; 1986 May; 39(5):537-42. PubMed ID: 3516511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muzolimine in the treatment of essential arterial hypertension not controlled with other antihypertensive drugs.
    Beneitez C
    Z Kardiol; 1985; 74 Suppl 2():52-5. PubMed ID: 4002805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muzolimine as monotherapy in the treatment of patients with congestive cardiac failure.
    Oversohl K; Mehrabian G; Hanisch M; Schmitz H
    Z Kardiol; 1985; 74 Suppl 2():27-31. PubMed ID: 4002800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of two different doses of muzolimine in the treatment of mild hypertension.
    Cocchieri M; Chiuini E; Fortunati F; Fedeli L; Solinas P
    Z Kardiol; 1985; 74 Suppl 2():56-9. PubMed ID: 4002806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of muzolimine after acute and chronic dosing in hypertensive patients with mild renal insufficiency.
    Mann J; Ritter W; Heckmann N; Sörgel F; Ritz E
    Z Kardiol; 1985; 74 Suppl 2():77-9. PubMed ID: 4002808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of muzolimine and furosemide in heart failure.
    Salerno M; Di Salvo M; Furnari R; Vaccaro F; Licciardi S; Finocchiaro S
    Z Kardiol; 1985; 74 Suppl 2():32-3. PubMed ID: 4002801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of treatment with pindolol on the renin-angiotensin-aldosterone system, kidney function and electrolyte balance in patients with primary arterial hypertension].
    Wyrzykowski B; Suchecka-Rachoń K
    Pol Tyg Lek; 1986 Dec; 41(48):1516-20. PubMed ID: 3588365
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical study of muzolimine in acute renal failure, pharmacodynamics and pharmacokinetics.
    Bouletreau P; Meunier J; Kérihuel JC; Ritter W
    Z Kardiol; 1985; 74 Suppl 2():96-9. PubMed ID: 4002812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mefruside in clinical practice: activity and mechanism of action].
    Perpignano G; Busilacchi M; Verzetti G
    Clin Ter; 1969 May; 49(4):337-63. PubMed ID: 5795021
    [No Abstract]   [Full Text] [Related]  

  • 19. Is the antihypertensive effect of muzolimine due to volume depletion?
    Andreucci VE; Dal Canton A; Russo D; Veniero P; Oliva O; Cofelice E; Romano G
    Z Kardiol; 1985; 74 Suppl 2():43-7. PubMed ID: 3890393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of muzolimine and of a combination of hydrochlorothiazide/triamterene in healthy subjects and in nephrotic patients.
    Riechers G; Futerova M; Hanisch M; Ritter W; Kühn K
    Z Kardiol; 1985; 74 Suppl 2():103-8. PubMed ID: 4002782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.